Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xizang Weixinkang Pharmaceutical is a leading Chinese pharmaceutical company specializing in the R&D, production, and sales of injectable vitamins, trace elements, electrolytes, APIs and finished dosage forms. The company has significant commercial presence across China with over 800 employees and more than 13 subsidiaries. It operates three major technology platforms focused on advanced injection processes and large-scale formulation development. Its business covers over 3,000 medical institutions nationwide. The pipeline includes more than 40 R&D projects at various stages from pre-clinical to registration review.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xizang Weixinkang Pharmaceutical.